Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during February 2026'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has filed a routine disclosure with the exchanges about shares that were converted from physical to demat form during February 2026. Only 3,000 shares were newly dematerialized during the month, involving just two shareholders — M Ramanatha Pillai (2,000 shares) and Vishal Kapoor (1,000 shares). The total dematerialized shares stood at 6,11,04,526 as of February 28, 2026, split between NSDL (5,34,51,058 shares) and CDSL (76,53,468 shares). The filing was made under Regulation 74(5) of SEBI's Depositories and Participants Regulations, with the certificate issued by the company's Registrar and Transfer Agent, Skyline Financial Services Pvt. Ltd.
This is a standard monthly compliance filing with no material impact on the company or its shareholders. The negligible volume of dematerialization (3,000 shares out of over 6 crore) indicates no unusual activity and is unlikely to affect the stock price or shareholder structure.